Literature DB >> 1534342

Pro-inflammatory levels of interleukin-1 alpha-like bioactivity are present in the majority of open comedones in acne vulgaris.

E Ingham1, E A Eady, C E Goodwin, J H Cove, W J Cunliffe.   

Abstract

The factors that initiate the inflammatory response in acne are not known. The presence of pro-inflammatory cytokines in acne comedones was therefore investigated. One hundred eight open comedones were collected from 18 untreated acne patients (10 male, 8 female). Each comedone was homogenized and centrifuged, and the supernatant was analyzed for bioactive and immunochemically detectable IL-1 alpha, IL-1 beta, and TNF alpha. Viable counts of propionibacteria, staphylococci, and Malassezia spp. were determined in the comedone pellet. Bioactive IL-1 alpha-like material was demonstrated in 76% of open comedones (range of 23-4765 pg IL-1 alpha-like bioactivity/mg of comedone material). In 58% of comedones, levels exceeded 100 pg/mg. There was no correlation between IL-1 alpha-like bioactivity and IL-1 alpha determined immunochemically. Bioactive IL-1 beta was not detected in any comedones. Twenty-four percent contained low levels of immunochemical IL-1 beta (range 12-103 pg IL-1 beta/mg comedone material). Bioactive TNF alpha was detected in three comedones with a further five comedones containing immunochemical TNF alpha (range of 61-820 pg TNF alpha/mg comedone material). The majority of open comedones (97%) contained microorganisms. There was, however, no significant correlation (Spearman's rank) between levels of any cytokine, in particular IL-1 alpha-like bioactivity, and numbers of microorganisms. Thus, bioactive IL-1 alpha-like material in the majority of open comedones may be concerned in the initiation of inflammation in acne following spongiosis or rupture of the pilosebaceous follicle wall.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534342     DOI: 10.1111/1523-1747.ep12460324

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  32 in total

Review 1.  [Pathophysiology of acne].

Authors:  C Borelli; G Plewig; K Degitz
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

2.  [Pathophysiology of acne. What is confirmed?].

Authors:  C C Zouboulis
Journal:  Hautarzt       Date:  2013-04       Impact factor: 0.751

3.  The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris.

Authors:  Ruta Ganceviciene; Markus Böhm; Sabine Fimmel; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2009-05

4.  Role of FGFR2-signaling in the pathogenesis of acne.

Authors:  Bodo C Melnik
Journal:  Dermatoendocrinol       Date:  2009-05

5.  Inflammasome activation by Propionibacterium acnes: the story of IL-1 in acne continues to unfold.

Authors:  Diane M Thiboutot
Journal:  J Invest Dermatol       Date:  2014-03       Impact factor: 8.551

6.  Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne.

Authors:  Nicholas Schmidt; Eugene H Gans
Journal:  J Clin Aesthet Dermatol       Date:  2011-11

Review 7.  Cutaneous lesions of the nose.

Authors:  Michael Sand; Daniel Sand; Christina Thrandorf; Volker Paech; Peter Altmeyer; Falk G Bechara
Journal:  Head Face Med       Date:  2010-06-04       Impact factor: 2.151

8.  In vitro modulation of keratinocyte-derived interleukin-1 alpha (IL-1 alpha) and peripheral blood mononuclear cell-derived IL-1 beta release in response to cutaneous commensal microorganisms.

Authors:  C E Walters; E Ingham; E A Eady; J H Cove; J N Kearney; W J Cunliffe
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

Review 9.  Current concepts of the pathogenesis of acne: implications for drug treatment.

Authors:  Harald Gollnick
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  IL-17: a key player in the P. acnes inflammatory cascade?

Authors:  Diane M Thiboutot; Alison M Layton; E Anne Eady
Journal:  J Invest Dermatol       Date:  2014-02       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.